---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-041399"
form_type: "8-K"
ticker: "DNA"
cik: "0001830214"
company_name: "Ginkgo Bioworks Holdings, Inc."
filed_at: "2025-08-29T23:59:59+00:00"
generated_at: "2026-05-17T09:17:49.662707+00:00"
event_type: "litigation"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Court grants preliminary approval to Ginkgo Bioworks derivative settlement; $4.125M from insurance

## Summary
- Company receives $4.125M from insurance; plaintiffs' counsel may request $2.75M in fees.
- Settlement requires Ginkgo to adopt corporate governance reforms.
- Derivative actions (Hu, Bowers, In re Ginkgo) will be dismissed with prejudice.
- Final hearing set for December 18, 2025; settlement entered on May 27, 2025.

## SEC filing metadata
- accession: 0001628280-25-041399
- form_type: 8-K
- ticker: DNA
- cik: 0001830214
- company_name: Ginkgo Bioworks Holdings, Inc.
- filed_at: 2025-08-29T23:59:59+00:00
- event_type: litigation
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1830214/000162828025041399/0001628280-25-041399-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1830214/000162828025041399/dna-20250829.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-041399
- JSON: https://secwatch.observer/filing/0001628280-25-041399.json
- Plain text: https://secwatch.observer/filing/0001628280-25-041399.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.